Lexeo Therapeutics, Inc To Start Trading Tomorrow

Lexeo Therapeutics, Inc LXEO IPO will take place November, 03 on the NASDAQ exchange under the ticker LXEO.

The company is offering shares at an expected price between $13.00 and $15.00 per share with an insider lock-up period of 180 days ending on May 01, 2024.

See also: Benzinga IPO Calendar

About Lexeo Therapeutics, Inc

Lexeo Therapeutics, Inc is a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.